About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Vaccine Induced Adaptive Immune Responses

COVID-19 Vaccine Induced Adaptive Immune Responses

NCT04729374·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Chao Wu, M.D., Ph.D
CONTACT
+8613809022921 dr.wu@nju.edu.cn
Yuxin Chen, Ph.D
CONTACT
+8617714413628 yuxin_chen2015@163.com

Lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Age

18–59

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy and aged between 18 to 59 years

You may not be if

High-risk epidemiology history within 14 days before enrollment
SARS-CoV-2 specific IgG or IgM positive in serum
Positive PCR test for SARS-CoV-2 from pharyngeal or anal swab samples
Axillary temperature of more than 37·0°C
Known allergy to any vaccine component
Thyroid disease

The record

StatusUnknown

PhaseNo phase

Taking part200

StartedJan 2021

UpdatedFeb 5, 2021

Conditions

SARS-CoV-2 Vaccine COVID-19

Where1

Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China